Tag Archives: Pfizer’s

Pfizer’s Xeljanz drops off top June TV spenders list—and Gilead’s Biktarvy fills the void

AbbVie remained the top pharma TV ad spender with Humira in June, and Gilead Sciences continued its TV push for Biktarvy and Truvada. But one long-time list placeholder dropped out of sight: Pfizer’s Xeljanz spent no money on TV ads in June, according to data from real-time TV ad tracker iSpot.tv. That’s unusual for the rheumatoid arthritis and… Read More »

Cue the ‘revolving door’ criticism: Former FDA commissioner Gottlieb joins Pfizer’s board

When former FDA commissioner Scott Gottlieb, M.D., resigned back in March, he said he wanted to spend more time with his family. Since then, Gottlieb has nabbed a partnership at a VC firm and a think tank fellowship. And now, less than three months since his last day regulating pharma, Gottlieb has joined Pfizer, one… Read More »